For decades, the United States has shouldered a disproportionate share of global pharmaceutical costs, accounting for 70% of global biopharma profits and over 80% of new drug launches. While this has helped drive significant medical innovation and supported the majority of global drug launches, it has also resulted in higher out-of-pocket costs for American patients.

As the maritime world sails deeper into digital waters, cyber threats are no longer just an IT issue — they’re a boardroom priority. Discover the critical actions executives must take to safeguard resilience, reputation, and deal value in a high-stakes, high-risk seascape.

يدرس هذا التقرير أداء أكبر عشرة بنوك مدرجة في المملكة للفترة المذكورة، وقد أكد البداية القوية للقطاع المصرفي السعودي لهذا العام، متمثلةً في تحسّن الربحية وضبط التكلفة وتسارع نمو ائتمان الشركات.